Our Leadership

In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.

In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.

Corporate Leadership

Dalvir Gill
Chief Executive Officer, TransCelerate BioPharma Inc.
Andy Lee
Senior Vice President, Head of Global Clinical Trial Operations, Merck
Ülo Palm
Senior Vice President, Drug Development Operations, Allergan
Janice Chang
Senior Vice President, Global Operations, TransCelerate BioPharma, Inc.

Board of Directors

Elliott Levy
Senior Vice President, Global Development, Amgen
David Nicholson
Executive Vice President and Chief R&D Officer, Allergan
Roy Baynes
Senior Vice President, Global Clinical Development, Merck Research Laboratories
Sean Bohen
Executive Vice President, Global Medicines Development, and Chief Medical Officer, AstraZeneca Pharmaceuticals
Patrizia Cavazzoni
Senior Vice President, Worldwide Head of Development Operations, Pfizer
Christopher Corsico
Senior Vice President, Corporate Division Medicine and Chief Medical Officer, Boehringer Ingelheim GmbH
Anne Bording Jensen
Senior Vice President, Clinical Operations, Novo Nordisk A/S
Iris Loew-Friedrich
Executive Vice President and Chief Medical Officer, UCB
Jan Lundberg
Executive Vice President of Science and Technology, Eli Lilly & Co.
Rod MacKenzie
Executive Vice President, Chief Development Officer, Pfizer Inc.
Kate Owen
Head of Global Clinical Operations (GCO), Bristol-Myers Squibb
Alise Reicin
Senior Vice President, Head of Global Clinical Development, EMD Serono, Inc.
Michelle Rohrer
Senior Vice President, Global Head of Pharma Regulatory and Policy, Roche
Kathy Rouan
SVP and Head of Projects, Clinical Platforms and Sciences (PCPS), GSK
Takuko Sawada
Senior Executive Officer, Executive General Manager, Global Development, Shionogi & Co., Ltd.
Rob Scott
Chief Medical Officer, AbbVie
Badhri Srinivasan
Head, Global Development Operations, Novartis
Paul Stoffels
Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
Elias Zerhouni
President of Global R&D, Sanofi
Bernhardt Zeiher
President, Global Development, Astellas Pharma